Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease
about
A systematic review of disease-related stigmatization in patients living with inflammatory bowel diseaseDistance management of inflammatory bowel disease: systematic review and meta-analysisEthical considerations for clinical trials in inflammatory bowel diseaseInflammatory bowel disease: an expanding global health problemSocioecologic factors as predictors of readiness for self-management and transition, medication adherence, and health care utilization among adolescents and young adults with chronic kidney disease.Racial disparities in readmission, complications, and procedures in children with Crohn's diseaseBiologics in paediatric Crohn's disease.Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.Investigation of potential early Histologic markers of pediatric inflammatory bowel disease.Progress in the treatment and outcome of pediatric inflammatory bowel disease patients.Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.Trends in early outpatient drug therapy in pediatric inflammatory bowel disease in Finland: a nationwide register-based study in 1999-2009.Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility Study.Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population.Variation in Antibiotic Use for Children Hospitalized With Inflammatory Bowel Disease Exacerbation: A Multicenter Validation Study.Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.Crohn's disease and the mycobacterioses: a quarter century later. Causation or simple association?Telemedicine in inflammatory bowel disease: opportunities and approaches.Longitudinal Patterns of Medication Nonadherence and Associated Health Care Costs.Hospital-Acquired Conditions Are Associated with Worse Outcomes in Crohn's Disease-Related Hospitalizations.The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future.Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada: A Distinct Clinical Phenotype.Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA.Early readmission in patients hospitalized for ulcerative colitis: incidence and risk factors.Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010-2014.A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases.The burden of comedication among patients with inflammatory bowel disease.Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus.Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.Predicting Costs of Care for Patients With Inflammatory Bowel Diseases.Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009.Use of telemedicine in inflammatory bowel disease: a real monitoring option?Home Sweet Home? Will Medical Homes Be Coming to Your Neighborhood Sometime Soon?
P2860
Q26750421-47D90406-A581-4C91-BB6E-041D7B8D47EEQ30486789-F30C86CD-F10A-4985-A489-72C25212C734Q33561988-51336A2A-F021-420F-B239-F4ED04AD1D11Q33608406-4D288D1B-C25A-4F72-BD4E-889163BE9C69Q33888189-6305A851-9E8E-46C2-A907-3E7447851916Q35196246-1B1C414A-B3EE-414E-BFBB-5A7D4866F08CQ35579308-80F6E150-8367-4DE6-A92F-35B04F62F520Q35634488-00012266-3779-4091-ACF6-4ADF86C6BD75Q35805570-77A34011-CEA7-4568-8BE5-1B37474EC100Q36056969-8263752C-9CA7-4C09-9C40-89C6718C3715Q36130660-DFEAA22E-842A-4C26-B581-4A9A276B13F9Q36200041-FC591F44-8D3F-42B7-A36E-7C6BBF70937CQ36480443-7A6064B2-9CFA-4565-8E10-EDAA58A89C7EQ36622034-E9FBCF8B-32A4-494A-AD1F-DF57E1A695BEQ36851121-9FE020DF-7952-4F08-AB5E-F150F16D4BEDQ37118397-D92A5B40-05B3-47BC-A32E-D3C8A31B1BA9Q37975540-B0F0D08A-FCC4-426E-ADBE-99F06B904ACDQ38273299-B8A195FC-AD20-417A-913E-8753B47B0107Q38724407-C9D7B7B7-703A-45F1-B689-697390E71D66Q38841192-B4C3D4F5-94F5-4DB8-B067-0A57ADD375C5Q38895422-39B817A0-27CD-4E5C-A759-9DF66FC0B6B4Q39052281-CD04F489-CBC3-4735-8D2F-9654E10A0711Q39252060-A7B136CF-24BA-45B0-861F-05B1BCFACE5BQ40122530-D277A02A-DB8D-4FA6-B61F-6BD892294709Q40137016-9400DA64-A3D3-488A-B059-30F5BE8F7FCFQ41084648-32702771-7F74-4871-A377-CF1C4566F196Q41698379-966CDE1B-958C-45AF-AE62-7AC7572F806DQ44659399-4A785331-64EB-424F-9D5E-9B5AE1996F70Q44995617-005B1572-2366-4472-87CC-E84EBF739E73Q45990517-3BFBBCB7-CCA1-48D7-9C04-D045D8FD481FQ47258552-FE2DAD59-56AA-4876-8192-84335DB36498Q47592510-FCF3D9BA-BE08-4ED8-84CD-853537277037Q48092176-32D767FD-6EAB-4B3C-BCF7-BB140494849CQ50319887-8D91FADC-3563-47E8-8C17-7D9A0E18859DQ51223309-944D6B8A-EE32-4078-8941-0BAD3D18327AQ51295017-8E10CD7A-D2A3-4E64-BF36-FE8E612FBB75Q53992652-A4F7F15D-6C7A-42A9-90C0-EE7D62D56A86
P2860
Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Utilization of healthcare reso ...... ith inflammatory bowel disease
@ast
Utilization of healthcare reso ...... ith inflammatory bowel disease
@en
Utilization of healthcare reso ...... ith inflammatory bowel disease
@nl
type
label
Utilization of healthcare reso ...... ith inflammatory bowel disease
@ast
Utilization of healthcare reso ...... ith inflammatory bowel disease
@en
Utilization of healthcare reso ...... ith inflammatory bowel disease
@nl
prefLabel
Utilization of healthcare reso ...... ith inflammatory bowel disease
@ast
Utilization of healthcare reso ...... ith inflammatory bowel disease
@en
Utilization of healthcare reso ...... ith inflammatory bowel disease
@nl
P2093
P2860
P356
P1476
Utilization of healthcare reso ...... ith inflammatory bowel disease
@en
P2093
Carol Q Porter
Daniel A Ollendorf
Jonathan A Finkelstein
Joseph A Galanko
Michael D Kappelman
Sheryl L Rifas-Shiman
P2860
P356
10.1002/IBD.21371
P577
2011-01-01T00:00:00Z